Answers are grounded in this paper and cite their sources.
Congenital factor VII (FVII) deficiency, also known as hypoproconvertinemia, is a rare autosomal recessive bleeding disorder that affects the extrinsic coagulation pathway. This case report describes the peripartum anesthetic and hematological management of a 31-year-old female, a primigravida, who presented for delivery with a known, moderate-to-severe FVII deficiency. The primary management challenge involved carefully balancing the risk of massive postpartum hemorrhage against the thrombotic risks associated with FVII replacement therapy. The patient was successfully managed through a multidisciplinary team approach and the pre-emptive administration of recombinant activated FVII. Monitoring, including thromboelastography (TEG), was utilized, which, despite the known limitations of Kaolin TEG in isolated FVII deficiency, helped guide management. An uneventful Cesarean section was performed under general anesthesia. This case highlights the critical importance of meticulous, multidisciplinary collaboration in managing this high-risk obstetric population.
No takes yet. Share an insight, caveat, or question.
Puthenveettil et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: